M E 32 (Erlotinib Hydrochloride 100 mg)

Pill with imprint M E 32 is White, Round and has been identified as Erlotinib Hydrochloride 100 mg. It is supplied by Mylan Pharmaceuticals Inc.

Erlotinib is used in the treatment of non-small cell lung cancer; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Erlotinib 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M E 32

Erlotinib Hydrochloride

Imprint

M E 32

Strength

100 mg

Color

White

Shape

Round

Availability

Prescription only

Drug Class

EGFR inhibitors

Pregnancy Category

D - Positive evidence of risk

CSA Schedule

Not a controlled drug

Labeler / Supplier

Mylan Pharmaceuticals Inc.

National Drug Code (NDC)

00378-7132

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "M E 32"

Mevacor

Loxitane

Minizide

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer